For someone starting at 8.0%, this could mean reaching 6.5-7.0%, potentially meeting treatment targets
Meaning a substantial majority of patients, 499 out of 500, would never experience an increased risk from being on these drugs. What are the Signs Youre Experiencing Eye Changes or Vision Loss From Drugs Like Ozempic
Excretion Pathways Limited data exists on specific excretion pathways for topically applied Syn-AKE: Degradation products likely eliminated through normal peptide metabolic pathways Renal clearance probable for any systemically absorbed peptide or fragments No accumulation detected in repeated-use studies (manufacturer data) Excretion kinetics require further investigation through labeled peptide studies The reversible nature of Syn-AKEs effects and absence of reported accumulation issues suggest efficient clearance mechanisms, though detailed elimination studies are lacking in peer-reviewed literature
The chronic use of any of these medications has the potential to cause complications related to vitamin B12 deficiency, which includes impaired DNA synthesis, impaired cell division, hematopoiesis, hyperhomocysteinemia, and metabolism of odd-chain fatty acids that is necessary in preventing demyelination of nerves